9 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021
-
06/2004 |
7 | AntigensIBA
01/2023
-
01/2018 |
7 | Somatostatin Receptors (Somatostatin Receptor)IBA
01/2021
-
02/2010 |
7 | Edotreotide (SMT 487)IBA
09/2020
-
02/2010 |
6 | Biomarkers (Surrogate Marker)IBA
11/2023
-
08/2015 |
6 | Glucose (Dextrose)FDA LinkGeneric
12/2019
-
10/2005 |
5 | Peptide Receptors (Peptide Receptor)IBA
06/2022
-
02/2014 |
5 | Radioisotopes (Radionuclides)IBA
06/2022
-
02/2014 |
4 | 2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
03/2023
-
10/2015 |
4 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2021
-
01/2019 |
3 | Peptides (Polypeptides)IBA
10/2021
-
01/2019 |
3 | Ga(III)-DOTATOCIBA
01/2020
-
01/2012 |
3 | EnzymesIBA
12/2019
-
08/2008 |
3 | Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
08/2017
-
07/2013 |
2 | DOTA(0)-Tyr(3)- 177Lu-octreotideIBA
10/2021
-
01/2021 |
2 | Prostate-Specific Antigen (Semenogelase)IBA
03/2021
-
01/2021 |
2 | RadiopharmaceuticalsIBA
01/2021
-
02/2020 |
2 | gallium 68 PSMA-11IBA
06/2019
-
01/2018 |
2 | N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
12/2017
-
01/2016 |
2 | alovudineIBA
09/2008
-
08/2008 |
2 | salicylhydroxamic acid (SHAM)IBA
03/2004
-
04/2003 |
1 | EverolimusFDA Link
01/2024 |
1 | AlpelisibIBA
01/2024 |
1 | Auranofin (Ridaura)FDA Link
11/2023 |
1 | LutetiumIBA
11/2023 |
1 | gadobutrolIBA
10/2022 |
1 | FluoridesIBA
10/2022 |
1 | A-factor (Streptomyces)IBA
10/2021 |
1 | gonadotropin releasing hormone associated peptideIBA
05/2021 |
1 | Proteasome InhibitorsIBA
01/2021 |
1 | DNA (Deoxyribonucleic Acid)IBA
01/2021 |
1 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2021 |
1 | Bortezomib (Velcade)FDA Link
01/2021 |
1 | Proteins (Proteins, Gene)FDA Link
01/2021 |
1 | 177Lu-DOTA-JR11IBA
01/2021 |
1 | Anaplastic Lymphoma KinaseIBA
08/2020 |
1 | 68Ga-pentixaforIBA
02/2020 |
1 | 4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA
01/2020 |
1 | PlatinumIBA
12/2019 |
1 | animacroxamIBA
12/2019 |
1 | Histone Deacetylases (Histone Deacetylase)IBA
12/2019 |
1 | Histone Deacetylase InhibitorsIBA
12/2019 |
1 | ChemokinesIBA
01/2019 |
1 | CateninsIBA
01/2019 |
1 | Type 1 Melanocortin ReceptorIBA
01/2019 |
1 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2019 |
1 | Transcription Factors (Transcription Factor)IBA
01/2019 |
1 | acetyl0Nle(4)-Asp(5)-Phe(7)- alpha-MSH (4-11)IBA
01/2019 |
1 | ethylenediamine (ethylenediamine dihydroiodide)FDA Link
12/2017 |
1 | Complement System Proteins (Complement)IBA
12/2017 |
1 | AcidsIBA
12/2017 |
1 | GalliumIBA
12/2017 |
1 | Alkaline PhosphataseIBA
01/2017 |
1 | PSMA-617IBA
01/2017 |
1 | 177Lu-PSMA-617IBA
01/2017 |